Ischemia Care, a Cincinnati-based company that combines bioinformatics and medical devices for stroke detection, is in the midst of raising up to $5 million, according to a filing with the SEC. So far, Ischemia Care, founded in 2009, has raised $1.9 million through equity offerings, with an additional $3.1 million to be sold, according to […]
A startup that’s developing a blood test to diagnose the cause of stroke is planning a clinical study that could pave the way to commercial sales of the test. Cincinnati-based IschemiaCare plans to begin the study in the second half of this year, and the young company has attracted some big-name partners to help it […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A startup that’s hoping to be the first to commercialize a blood test that can diagnose the cause of stroke has received a state loan for nearly $1 million. The $943,000 in financing for Cincinnati-area IschemiaCare comes through the Innovation Ohio Loan Fund program, which is aimed at helping companies in the state develop “next-generation” […]
A company that’s hoping to be the first to commercialize a blood test that can diagnose the cause of stroke has closed $800,000 of an anticipated $1.1 million series B round of investment. Cincinnati-area-based IschemiaCare expects to close on the full $1.1 million by the end of the year. The funding will enable the company […]